Alkem Laboratories Ltd (NSE:ALKEM) Share Price

Company Profile

Business description
Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.
Contact
Senapati Bapat Marg
Alkem House, Devashish Building
Lower Parel
MumbaiMH400 013
IND
T: +91 2239829999
https://www.alkemlabs.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
22,833

Recommended

We believe a competitive—if not leading—AI feature suite will reinforce Apple’s wide-moat mobile device ecosystem.

William Kerwin, CFA | 12 January 2026

The shares are overvalued as investors are overly excited about defence and gold exposure.

Esther Holloway | 12 January 2026

Our view on the potential for additional offers.

Esther Holloway | 11 January 2026

Index	Last price	Change	% Change
All Ordinaries	9,138.50	11.40	0.12%
CAC 40	8,313.00	45.76	-0.55%
DAX 40	25,349.15	56.19	-0.22%
Dow JONES (US)	49,590.20	86.13	0.17%
FTSE 100	10,141.63	0.93	0.01%
HKSE	26,848.47	239.99	0.90%
NASDAQ	23,733.90	62.56	0.26%
Nikkei 225	53,549.16	1,609.27	3.10%
NZX 50 Index	13,656.05	27.24	-0.20%
S&P 500	6,977.27	10.99	0.16%
S&P/ASX 200	8,808.50	17.20	0.20%
SSE Composite Index	4,138.76	26.53	-0.64%